Adane J, Robbins PD (1995): The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. Oncogene 10: 381–387 Google Scholar
Albert T, Urlbauer B, Kohlhuber F, Hammersen B, Eick D (1994): Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt’s lymphoma cell lines. Oncogene 9: 759–763 PubMedCAS Google Scholar
Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H (1992): Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423–426 ArticlePubMedCAS Google Scholar
Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H (1993a): Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72: 233–245 ArticlePubMedCAS Google Scholar
Amati B, Littlewood TD, Evan GI, Land H (1993b): The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12: 5083–5087 PubMedCAS Google Scholar
Ariga H, Imamura Y, Iguchi-Ariga SMM (1989): DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences. EMBO J 8: 4273–4279 PubMedCAS Google Scholar
Askew DS, Ashmun RA, Simmons BC, Cleveland JL (1991): Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922 PubMedCAS Google Scholar
Auvinen M, Passinen A, Andersson LC, Holtta E (1992): Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355–358 ArticlePubMedCAS Google Scholar
Ayer DE, Eisenman RN (1993): A switch from myc-max to mad-max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7: 2110–2119 ArticlePubMedCAS Google Scholar
Ayer DE, Kretzner L, Eisenman RN (1993): Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211–222 ArticlePubMedCAS Google Scholar
Ayer DE, Lawrence QA, Eisenman RN (1995): Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of the yeast repressor Sin3. Cell 80: 767–776 ArticlePubMedCAS Google Scholar
Barone MV, Courtneidge SA (1995): Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378: 509–512 ArticlePubMedCAS Google Scholar
Barrett J, Birrer MJ, Kato GJ, Dosaka AH, Dang CV (1992): Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol 12: 3130–3137 PubMedCAS Google Scholar
Beckmann H, Su L-K, Kadesch T (1990): TFE3: A helix-loop-helix protein that activates transcription through the immunoglobulin enhancer mE3 motif. Genes Dev 4: 167–179 ArticlePubMedCAS Google Scholar
Beijersbergen RL, Hijmans EM, Zhu L, Bernards R (1994): Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J 13: 4080–4086 PubMedCAS Google Scholar
Bello-Fernandes C, Packham G, Cleveland JL (1993): The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90: 7804–7808 Article Google Scholar
Benvenisty N, Leder A, Kuo A, Leder P (1993): An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev 6: 2513–2523 Article Google Scholar
Berberich SJ, Cole MD (1992): Casein kinase II inhibits the DNA binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev 6: 166–176 ArticlePubMedCAS Google Scholar
Berberich S, Hyde-deRuyscher N, Espenshade P, Cole M (1992): Max encodes a sequence-specific DNA binding protein and is not regulated by serum growth factors. Oncogene 7: 775–779 PubMedCAS Google Scholar
Bernards R (1995): Transcriptional regulation: flipping the Myc switch. Curr Biol 5: 859–861 ArticlePubMedCAS Google Scholar
Bestor TH (1990): DNA methylation: evolution of a bacterial immune function into a regulator of gene expression and genome structure in higher eukaryotes. Phil Trans R Soc Lond B 326: 179–187 ArticleCAS Google Scholar
Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I (1993): Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas. Nat Genet 5: 56–61 ArticlePubMedCAS Google Scholar
Bhatia K, Spangler G, Gaidano G, Hamdy N, Dalla-Favera R, Magrath I (1994): Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84: 883–888 PubMedCAS Google Scholar
Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, Minna JD (1988): L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol 8: 2668–2673 PubMedCAS Google Scholar
Blackwell TK, Weintraub H (1990): A new binding-site selection technique reveals differences and similarities between MyoD and E2A DNA-binding specificities. Science 250: 1104–1110 ArticlePubMedCAS Google Scholar
Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H (1993): Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 13: 5216–5224 PubMedCAS Google Scholar
Blackwood E, Eisenman RN (1991): Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211–1217 ArticlePubMedCAS Google Scholar
Blackwood E, Lüscher B, Eisenman RN (1992): Myc and Max associate in vivo. Genes Dev 6: 71–80 ArticlePubMedCAS Google Scholar
Born T, Frost J, Schönthal A, Prendergast GC, Feramisco J (1994): c-Myc and oncogenic ras induce the cdc2 promoter. Mol Cell Biol 14: 5741–5747 Article Google Scholar
Bousset K, Henriksson M, Lüschner-Firzlaff JM, Litchfield DW, Lüscher B (1993): Oncogene 8: 3211–3220 PubMedCAS Google Scholar
Boyd JM, Subramanian T, Schaeper U, LaRegina M, Bayley S, Chinnadurai G (1993): A region in the C-terminus of adenovirus 2/5 Ela protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis, and metastasis. EMBO J 12: 469–478 PubMedCAS Google Scholar
Brough DE, Hofrnan TJ, Ellwood KB, Townley RA, Cole MD (1995): An essential domain of the c-Myc protein interacts with a nuclear factor that is also required for ElA-mediated transformation. Mol Cell Biol 15: 1536–1544 PubMedCAS Google Scholar
Cerni C, Mougneau E, Cuzin F (1987): Transfer of “immortalizing” oncogenes in rat fibroblasts induces both high rates of sister chromatid exchange and appearance of abnormal karotypes. Exp Cell Res 168: 439–446 ArticlePubMedCAS Google Scholar
Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Luscher B (1995): Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11: 587–596 PubMedCAS Google Scholar
Chen J, Willingham T, Margraf LR, Schreiber-Agus N, De Pinho RA, Nisen PD (1995): Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med 1: 638–643 ArticlePubMedCAS Google Scholar
Chin L, Schreiber-Agus N, Pellicer I, Chen K, Lee HW, Dudast M, Cordon-Cardo C, De Pinho RA (1995): Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci USA 92: 8488–8492 ArticlePubMedCAS Google Scholar
Chou TY, Dang CV, Hart GW (1995): Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci USA 92: 4417–4421 ArticlePubMedCAS Google Scholar
Cole MD (1986): The myc oncogene: Its role in transformation and differentiation. Ann Rev Genet 20: 361–384 ArticlePubMedCAS Google Scholar
Dang C, McGuire M, Buckmire M, Lee WMF (1989): Involvement of the “leucine zipper” region in the oligomerization and transforming activity of human c-myc protein. Nature 337: 664–666 ArticlePubMedCAS Google Scholar
Dang CV, Lee WMF (1989): Nuclear and nucleolar targeting sequences of c-erbA, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem 264: 18019–18023 PubMedCAS Google Scholar
Dang CV, v. Dam H, Buckmire M, Lee WMF (1989): DNA-binding domain of human c-Myc produced in Escherichia coll Mol Cell Biol 9: 2477–2486 CAS Google Scholar
Dang CV, Barrett J, Villa-Garcia M, Resar LMS, Kato GJ, Fearon ER (1991): Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization. Mol Cell Biol 11: 954–962 PubMedCAS Google Scholar
De Pinho RA, Schreiber-Agus N, Alt FW (1991): myc family oncogenes in the development of normal and neoplastic cells. Adv Cane Res 57: 1–46 Article Google Scholar
Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995): Mutation of the MXI1 gene in prostate cancer. Nat Genet 9: 249–255 ArticlePubMedCAS Google Scholar
Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M (1994): Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci 345: 215–269 Google Scholar
Evan GI, Littlewood TD (1993): The role of c-myc in cell growth. Curr Opin Genet Dev 3: 44–49 ArticlePubMedCAS Google Scholar
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Perm LZ, Hancock DC (1992): Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128 ArticlePubMedCAS Google Scholar
Evan GI, Brown L, Whyte M, Harrington E (1995): Apoptosis and the cell cycle. Curr Biol 7: 825–834 CAS Google Scholar
Ferre-D’Amare A, Prendergast GC, Ziff EB, Burley SK (1993): Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363: 38–45 ArticleCAS Google Scholar
Fiol CJ, Wang A, Roeske RW, Roach PJ (1990): Ordered multisite protein phosphoryla-tion: Analysis of glycogen synthase kinase 3 action using model peptide substrates. J Biol Chem 265: 6061–6065 PubMedCAS Google Scholar
Fisher DE, Parent LA, Sharp PA (1992): Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. Proc Natl Acad Sci USA 89: 11779–11783 ArticlePubMedCAS Google Scholar
Fisher F, Jayaraman P-S, Goding CR (1991): C-Myc and the yeast transcription factor PHO4 share a common CACGTG binding motif. Oncogene 6: 1099–1104 PubMedCAS Google Scholar
Frykberg L, Graf T, Vennström B (1987): The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene 1: 415–421 PubMedCAS Google Scholar
Gaubatz S, Meichle A, Eilers M (1994): An E-box element localized in the first intron mediates regulation of the prothymosin α gene by c-myc. Mol Cell Biol 14: 3853–3862 PubMedCAS Google Scholar
Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M (1995): Transcriptional activation by Myc is under negative control by the transcription factorAP-2. EMBO J 14: 1508–1519 PubMedCAS Google Scholar
Gibson AW, Ye R, Johnston RN, Browder LW (1992): A possible role for c-Myc onco-proteins in post-transcriptional regulation if ribosomal RNA. Oncogene 7: 2363–2367 PubMedCAS Google Scholar
Gregor PD, Sawadogo M, Roeder RG (1990): The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev 4: 1730–1740 ArticlePubMedCAS Google Scholar
Gu W, Cechova K, Tassi V, Dalla FR (1993): Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci USA 90: 2935–2939 ArticlePubMedCAS Google Scholar
Gu W, Bhatia K, Magrath IT, Dang CV, DallaFavera R (1994): Binding and suppresion of the myc transcriptional activation domain by p107. Science 264: 251–254 ArticlePubMedCAS Google Scholar
Gupta S, Seth A, Davis RJ (1993): Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci USA 90: 3216–3220 ArticlePubMedCAS Google Scholar
Gusse M, Ghysdael J, Evan G, Soussi T, Mechali M (1989): Translocation of a store of maternal cytoplasmic c-myc protein into nuclei during early development. Mol Cell Biol 9: 5395–5403 PubMedCAS Google Scholar
Halazonetis TD, Kandil AN (1991): Determination of the c-Myc DNA binding site. Proc Natl Acad Sci USA 6162–6166 Google Scholar
Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN (1988): A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt’s lymphomas. Cell 52: 185–195 ArticlePubMedCAS Google Scholar
Hann SR, Dixit M, Sears RC, Sealy L (1994): The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev 8: 2441–2452 ArticlePubMedCAS Google Scholar
Hanson KD, Shichiri M, Follansbee MR, Sedivy JM (1994): Effects of c-myc expression on cell cycle progression. Mol Cell Biol 14: 5748–5755 ArticlePubMedCAS Google Scholar
Hateboer G, Timmers H, Rustgi AK, Billaud M, Van’tVeer LJ, Bernards R (1993): TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus ElA protein. Proc Nail Acad Sci USA 90: 8489–8493 ArticleCAS Google Scholar
Heaney ML, Pierce J, Parsons JT (1986): Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J Virol 60: 167–176 PubMedCAS Google Scholar
Henriksson M, Lüscher B (1996): Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Canc Res 68: 109–182 ArticleCAS Google Scholar
Henriksson M, Classon M, Ingvarsson S, Koskinen P, Sumegi J, Klein G, Thyberg J (1988): Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization. Oncogene 3: 587–591 PubMedCAS Google Scholar
Henriksson M, Bakardjiev A, Klein G, Lüscher B (1993): Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8: 3199–3209 PubMedCAS Google Scholar
Hermeking H, Eick D (1994): Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091–2093 ArticlePubMedCAS Google Scholar
Hermeking H, Wolf DA, Kohlhuber F, Dickmanns A, Biollaud M, Fanning E, Eick D (1994): Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci USA 91: 10412–10416 ArticlePubMedCAS Google Scholar
Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV (1994): Participation of cy-clin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91: 6875–6879 ArticlePubMedCAS Google Scholar
Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou T-Y, Barrett JF, Raffeld M, Hann SR, Dang CV (1995): A link between increase transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol 15: 4031–4042 PubMedCAS Google Scholar
Hopewell R, Ziff EB (1995): The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max. Mol Cell Biol 15: 3470–3478 PubMedCAS Google Scholar
Hu Y-F, Lüscher B, Admon A, Mermod N, Tjian R (1990): Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 4: 1741–1752 ArticlePubMedCAS Google Scholar
Huriin PJ, Ayer DE, Grandori C, Eisenman RN (1994): The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb. Symp Quant Biol 59: 109–116 Article Google Scholar
Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Dopeland NG, Jenkins NA, Eisenman RN (1995): Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14: 5646–5659 PubMedCAS Google Scholar
Iguchi-Ariga SMM, Okazaki T, Itani T, Ogata M, Sato Y, Ariga H (1988): An initiation site of DNA replication with transcriptional enhancer activity present in the c-myc gene. EMBO J 7: 3135–3142 PubMedCAS Google Scholar
Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM, Dalla-Favera R (1990): Down-regulation of LFA-1 adhesion receptors by c-Myc oncogene in human B lymphoblastoid cells. Science 250: 682–686 ArticlePubMedCAS Google Scholar
Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M (1993): Differential modulation of cyclin gene expression by MYC. ProcNatl Acad Sci USA 90: 3685–3689 ArticleCAS Google Scholar
Jones PA, Buckley JD (1990): The role of DNA methylation in cancer. Adv Canc Res 54: 1–23 ArticleCAS Google Scholar
Kato G, Lee WMF, Chen L, Dang C (1992): Max: Functional domains and interaction with c-Myc. Genes Dev 6: 81–92 ArticlePubMedCAS Google Scholar
Kato GJ, Barrett J, Villa-Garcia M, Dang CV (1990): An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914–5920 PubMedCAS Google Scholar
Kelly K, Siebenlist U (1986): The regulation and expression of c-myc in normal and malignant cells. Ann Rev Immunol 4: 317–338 ArticleCAS Google Scholar
Kerkhoff E, Bister K, Klempnauer K-H (1991): Sequence-specific DNA-binding by Myc proteins. Proc Natl Acad Sci USA 88: 4323–4327 ArticlePubMedCAS Google Scholar
Kim YH, Buchholz MA, Chrest FJ, Nordin AA (1994): Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J Immunol 152: 4328–4335 PubMedCAS Google Scholar
Koskinen PJ, Sistonen L, Evan G, Morimoto M, Alitalo K (1991): Nuclear colocalization of cellular and viral myc proteins with HSP70 in myooverexpressing cells. J Virol 65: 842–851 PubMedCAS Google Scholar
Koskinen PJ, Vastrik I, Makela TP, Eisenman RN, Alitalo K (1994): Cell Growth Diff 5: 313–320 PubMedCAS Google Scholar
Koskinen PJ, Ayer DE, Eisenman RN (1995): Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Diff 6: 623–629 PubMedCAS Google Scholar
Kretzner L, Blackwood EM, Eisenman RN (1992): Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426–429 ArticlePubMedCAS Google Scholar
Land H, Parada LF, Weinberg RA (1983): Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602 ArticlePubMedCAS Google Scholar
Lapdschultz WH, Johnson PF, McKnight SL (1987): The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759–1764 Google Scholar
Lane DP, Lu X, Hupp T, Hall PA (1994): The role of the p53 protein in the apoptotic response. Philos Trans R Soc Lond B Biol Sci 345: 277–280 ArticlePubMedCAS Google Scholar
Lane DP, Midgley CA, Hupp TR, Lu X, Vojtesek B, Picksley SM (1995): On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage. Philos Trans R Soc Lond B Biol Sci 347: 83–87 ArticlePubMedCAS Google Scholar
Lee LA, Dolde C, Barrett J, Wu CS, Dang CV (1996): A link between c-Myc-mediated transcriptional repression and neoplastic transformation. J Clin Invest 97: 1687–1695 ArticlePubMedCAS Google Scholar
Lemaitre JM, Bocquet S, Buckle R, Mechali M (1995): Selective and rapid nuclear trans-location of a c-Myc-containing complex after fertilization of Xenopus laevis eggs. Mol Cell Biol 15: 5054–5062 PubMedCAS Google Scholar
Li L, Nerlov C, Prendergast G, MacGregor D, Ziff EB (1994): c-Myc activates and represses target gene through the E-box Myc binding site and the core promoter region respectively. EMBO J 13: 4070–4079 PubMedCAS Google Scholar
Lüscher B, Eisenman RN (1990): New light on Myc and Myb. Part I. Myc. Genes Dev 4: 2025–2035 Article Google Scholar
Lüscher B, Kuenzel EA, Krebs EG, Eisenman RN (1989): Myc oncoproteins are phos-phorylated by casein kinase II. EMBO J 8: 1111–1119 PubMed Google Scholar
Lutterbach B, Hann SR (1994): Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 14: 5510–5522 PubMedCAS Google Scholar
Mäkelä TP, Koskinen PJ, Västrik I, Alitalo K (1992): Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation. Science 256: 373–377 ArticlePubMed Google Scholar
Marcu KB, Bossone SA, Patel AJ (1992): Myc function and regulation. Ann Rev Biochem 61: 809–860 ArticlePubMedCAS Google Scholar
Martel C, Lallemand D, Cremisi C (1995): Specific c-myc and max regulation in epithelial cells. Oncogene 10: 2195–2205 PubMedCAS Google Scholar
Martin SJ, Green DR (1995): Protease activation during apoptosis: death by a thousand cuts. Cell 82: 349–352 ArticlePubMedCAS Google Scholar
Miltenberger RJ, Sukow KA, Farnham PJ (1995): An E-box-mediated increase in cad transcription at the Gl/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol 15: 2527–2535 PubMedCAS Google Scholar
Moshier JA, Dosescu J, Skunca M, Luk GD (1993): Transformation of NIHβT3 cells by ornithine decarboxylase overexpression. Cane Res 53: 2618–2622 CAS Google Scholar
Muhle-Goll C, Nilges M, Pastore A (1995): The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers. Biochemistry 34: 13554–13564 ArticlePubMedCAS Google Scholar
Mukherjee B, Morgenbesser SD, De PR (1992): Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and transacting dominant mutants. Genes Dev 6: 1480–1492 ArticlePubMedCAS Google Scholar
Murre C, McCaw PS, Baltimore D (1989): A new DNA-binding and dimerization motif in immunoglublin enhancer binding, daughterless, MyoD, and Myc proteins. Cell 56: 777–783 ArticlePubMedCAS Google Scholar
Negishi Y, Iguchi-Agriga SMM, Ariga H (1992): Protein complexes bearing _myc_-like antigenicity recognize two distinct DNA sequences. Oncogene 7: 543–548 PubMedCAS Google Scholar
O’Shea EK, Rutkowski RH, Kim PS (1989): Evidence that the leucine zipper is a coiled coil. Science 245: 538–541 Article Google Scholar
Packham G, Cleveland JL (1994): Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 14: 5741–5747 ArticlePubMedCAS Google Scholar
Packham G, Cleveland J (1995): c-Myc and apoptosis. Biochim Biophys Acta 1242: 11–28 PubMed Google Scholar
Packham G, Cleveland JL (1996) c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13: 461–469 PubMedCAS Google Scholar
Perry ME, Levine AJ (1993): Tumor-suppressor p53 and the cell cycle. Curr Opin Genet Dev 3: 50–54 ArticlePubMedCAS Google Scholar
Persson H, Gray HE, Godeau F, Braunhut S, Bellvé AR (1986): Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens. Mol Cell Biol 6: 942–949 PubMedCAS Google Scholar
Philipp A, Schneider A, Väsrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M (1994): Repression of cyclin Dl: a novel function of Myc. Mol Cell Biol 14: 4032–4043 ArticlePubMedCAS Google Scholar
Prendergast GC, Cole MD (1989): Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol 9: 124–134 PubMedCAS Google Scholar
Prendergast GC, Ziff EB (1991): Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251: 186–189 ArticlePubMedCAS Google Scholar
Prendergast GC, Lawe D, Ziff EB (1991): Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotrans-formation. Cell 65: 395–407 ArticlePubMedCAS Google Scholar
Prendergast GC, Hopewell R, Gorham B, Ziff EB (1992): Biphasic effect of Max on Myc transformation activity and dependence on N-and C-terminal Max functions. Genes Dev 6: 2429–2439 ArticlePubMedCAS Google Scholar
Prochownik EV, Van Antwerp ME (1993): Differential patterns of DNA binding by myc and max proteins. Proc Natl Acad Sci USA 90: 960–964 ArticlePubMedCAS Google Scholar
Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR (1994): Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9: 59–70 PubMedCAS Google Scholar
Ralston R (1991): Complementation of transforming domains in E1A/myc chimaeras. Nature 353: 866–869 ArticlePubMedCAS Google Scholar
Reddy CD, Dasgupta P, Saikumar P, Du Jek H, Rauscher FJ, Reddy EP (1992): Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene 7: 2085–2092 PubMedCAS Google Scholar
Reisman D, Elkind NB, Roy B, Beamon J, Rotter V (1993): c-Myc transactivates the p53 promoter through a required downstream CACGTG motif. Cell Growth Diff 4: 57–65 PubMedCAS Google Scholar
Roy A, Carruthers C, Gutjahr T, Roeder RG (1993a): Direct role for Myc in transcription.initiation mediated by interactions with TFII-I. Nature 365: 359–361 ArticlePubMedCAS Google Scholar
Roy AL, Malik S, Meisterernst M, Roeder RG (1993b): An alternative pathway for transcription initiation involving TFII-I. Nature 365: 355–359 ArticlePubMedCAS Google Scholar
Rustgi AK, Dyson N, Bernards R (1991): Amino-terminal domains of c-myc and N-myc proteins, mediate binding to the retinoblastoma gene product. Nature 352: 541–544 ArticlePubMedCAS Google Scholar
Sakamuro D, Eviner V, Elliott K, Showe L, White E, Prendergast GC (1995): c-Myc induces apeptosis in epithelial cells by p53-dependent and p53-independent mechanisms. Oncogene 11: 2411–2418 PubMedCAS Google Scholar
Sakamuro D, Elliott K, Wechsler R, Prendergast GC (1996): Binl, a novel Myc-inter-acting protein with features of a tumor suppressor. Nature Genet 14: 17–69 Article Google Scholar
Saksela K, Mäkelä TP, Hughes K, Woodgett JR, Alitalo K (1992): Activation of protein kinase C increase phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene 7: 347–353 PubMedCAS Google Scholar
Sawyers CL, Callahan W, Witte ON (1992): Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70: 901–1010 ArticlePubMedCAS Google Scholar
Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G (1995): Molecular cloning and characterization of cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus El A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 92: 10467–10471 ArticlePubMedCAS Google Scholar
Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, De Pinho RA (1995): An amino-terminal domain of Mxil mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777–786 ArticlePubMedCAS Google Scholar
Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B (1994): The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14: 2352–2360 ArticlePubMedCAS Google Scholar
Seth A, Alvarez E, Gupta S, Davis RJ (1991): A phosphorylation site located in the N-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem 266: 23521–23524 PubMedCAS Google Scholar
Seth A, Gupta S, Davis RJ (1993): Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol 13: 4125–4136 PubMedCAS Google Scholar
Shantz LM, Pegg AE (1994): Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cane Res 54: 2313–2316 CAS Google Scholar
Shi L, Nishioka WK, Thng J, Bradbury EM, Litchfield DW, Greenberg AH (1994): Premature p34cdc2 activation required for apoptosis. Science 263: 1143–1145 ArticlePubMedCAS Google Scholar
Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T (1992): IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-Myc. Cell 70: 57–67 ArticlePubMedCAS Google Scholar
Shichiri M, Hanson KD, Sedivy JM (1993): Effects of c-myc expression on proliferation, quiescence, and the GO to G1 transition in nontransformed cells. Cell Growth Diff 4: 93–104 PubMedCAS Google Scholar
Showe LC, Ballantine M, Nishikura K, Erikson J, Kaji H, Croce CM (1985): Cloning and sequencing of a c-myc oncogene in a Burkitt’s lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol 5: 501–509 PubMedCAS Google Scholar
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (1993): Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262: 1889–1892 ArticlePubMedCAS Google Scholar
Sklar MD, Thompson E, Welsh MJ, Liebert M, Harney J, Grossman HB, Smith M, Prochownik EV (1991): Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol Cell Biol 11: 3699–3710 PubMedCAS Google Scholar
Smith MJ, Charron-Prochownik DC, Prochownik EV (1990): The leucine zipper of c-Myc is required d for full inhibition of erythroleukemia differentiation. Mol Cell Biol 10: 5333–5339 PubMedCAS Google Scholar
Spector DL, Watt RA, Sullivan NF (1987): The v-and c-myc oncogene proteins co-localize in situ with small nuclear ribonucleoprotein particles. Oncogene 1: 5–12 PubMedCAS Google Scholar
Spencer CA, Groudine M (1991): Control of c-myc regulation in normal and neoplastic cells. Adv Cane Res 56: 1–48 ArticleCAS Google Scholar
Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M (1995): Identification of a Myc-dependent step during the formation of active Gl cyclin-cdk complexes. EMBO J 14: 4814–4826 PubMedCAS Google Scholar
Stone J, de Lange T, Ramsay G, Jakobovits E, Bishop JM, Varmus H, Lee W (1987): Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7: 1697–1709 PubMedCAS Google Scholar
Street AJ, Blackwood E, Lüscher B, Eisenman RN (1990): Mutational analysis of the carboxyterminal casein kinase II phosphorylation site in human c-myc. Curr Top Microbiol Immunol 166: 251–258 ArticlePubMedCAS Google Scholar
Suetake I, Tajima S, Asano A (1993): Identification of two novel mouse nuclear proteins that bind selectively to a methylated c-Myc recognizing sequence. Nuc Acids Res 21: 2125–2130 ArticleCAS Google Scholar
Tobias KE, Shor J, Kahana C (1995): c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene 11: 1721–1727 PubMedCAS Google Scholar
Vastrik I, Makela TP, Koskinen PJ, Alitalo K (1995): Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max. Oncogene 11: 553–560 PubMedCAS Google Scholar
Wagner AJ, Meyers C, Laimins LA, Hay N (1993): c-myc induces the expression and activity ornithine decarboxylase. Cell Growth DiffA: 879–883 Google Scholar
Wagner AJ, Kokonitis JM, Hay N (1994): Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 wafl/cip1. Genes Dev 8: 2817–2830 ArticlePubMedCAS Google Scholar
Wechsler DS, Dang CV (1992): Opposite orientations of DNA bending by c-Myc and Max. ProcNatl Acad Sci USA 89: 7635–7639 ArticleCAS Google Scholar
Wechsler DS, Papoulas O, Dang CV, Kingston RE (1994): Differential binding of c-Myc and Max to nucleosomal DNA. Mol Cell Biol 14: 4097–4107 PubMedCAS Google Scholar
Wenzel A, Cziepluch C, Hamann U, Scnürmann J, Schwab M (1991): The N-Myc onco-protein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J 10: 3703–3712 PubMedCAS Google Scholar
Yang B-S, Gilbert JD, Freytag SO (1993): Overexpression of Myc suppresses CCAAT Transcription Factor/Nuclear Factor 1-dependent promoters in vivo. Mol Cell Biol 13: 3093–3102 PubMedCAS Google Scholar
Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeid M (1993): Clustered mutations in the second exon of the MYC gene in sporadic Burkitt’s lymphoma. Oncogene 8: 2141–2148 Google Scholar
Zervos AS, Gyuris J, Brent R ( 1993): Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223–232 ArticlePubMedCAS Google Scholar
Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E (1993): Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Gems Dev 7: 1111–1125 ArticleCAS Google Scholar
Zoidl G, Brockmann D, Esche H (1993): Deletion of the β-turn/α-helix motif at the exon 2β boundary of humaa c-Myc leads to loss of its immortalizating function. Gene 131: 269–274 ArticlePubMedCAS Google Scholar